Hepaswiss 25000IU Injection
Marketer
Swiss Parenterals Ltd
Salt Composition
Heparin (25000IU)
Overview Hepaswiss 25000IU Injection
HemoStat 25000IU Injection acts as a blood thinner, preventing the development of potentially dangerous blood clots. This medication inhibits clot formation in crucial areas such as the legs, lungs, and heart, and also restricts the enlargement of existing clots. Administration of HemoStat 25000IU Injection requires medical oversight; dosage frequency is determined and adjusted by your physician based on treatment effectiveness. Consistent use is vital for optimal results, regardless of perceived well-being, as it proactively mitigates future risks. Regular blood tests, including potassium and platelet level monitoring, may be conducted to assess treatment efficacy. Increased bleeding risk is a potential side effect; report any unusual bleeding (e.g., petechiae, hematuria, melena) immediately. Exercise caution with activities involving sharp objects and contact sports. Prior to commencing treatment, disclose any pre-existing health issues and a complete list of medications to your doctor. Consult your physician regarding the safety of using this injection during pregnancy.
Primary Ingredients of Hepaswiss 25000IU Injection
No text provided to rephrase.
Uses of Hepaswiss 25000IU Injection
Thrombosis prophylaxis
Major Benefits of Hepaswiss 25000IU Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Hepaswiss 25000IU Injection:
- Bleeding
- Erythema (skin redness)
How to use Hepaswiss 25000IU Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.
How Hepaswiss 25000IU Injection works:
Hepaswiss 25000IU Injection acts as a blood thinner, inhibiting the development of potentially dangerous blood clots. While it cannot break down pre-existing clots, it effectively hinders their expansion and subsequent vessel obstruction.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Hepaswiss 25000IU Injection is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Hepaswiss 25000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Hepaswiss 25000IU Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant. The negligible quantities of Hepaswiss 25000IU Injection present in breast milk are insufficient to cause harm to the baby.
DrivingSAFE
Driving ability is typically unaffected by Hepaswiss 25000IU Injection.
KidneySAFE IF PRESCRIBED
The injectable medication Hepaswiss 25000IU is considered safe for individuals with kidney conditions; no dosage alteration is advised. Nevertheless, disclosure of any pre-existing kidney disease to your physician is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Hepaswiss 25000IU Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Hepaswiss 25000IU Injection :
Omit a Hepaswiss 25000IU Injection dose? Seek your physician's advice.
Facts to Know About Hepaswiss 25000IU Injection
| Label | Value |
|---|---|
| Chemical Category | Glycosaminoglycan Sulfate |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | Unfractionated heparin |
3,018 People bought this recently